A detailed history of Resources Investment Advisors, Llc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 5,078 shares of BMRN stock, worth $342,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,078
Previous 6,585 22.89%
Holding current value
$342,155
Previous $542,000 34.32%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$69.02 - $93.84 $104,013 - $141,416
-1,507 Reduced 22.89%
5,078 $356,000
Q2 2024

Aug 02, 2024

BUY
$74.43 - $92.22 $72,197 - $89,453
970 Added 17.28%
6,585 $542,000
Q1 2024

May 10, 2024

SELL
$83.81 - $99.0 $8,045 - $9,504
-96 Reduced 1.68%
5,615 $490,000
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $27,210 - $35,168
357 Added 6.67%
5,711 $550,000
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $10,123 - $11,243
119 Added 2.27%
5,354 $473,000
Q2 2023

Aug 07, 2023

BUY
$86.68 - $100.3 $2,253 - $2,607
26 Added 0.5%
5,235 $453,000
Q1 2023

May 10, 2023

BUY
$87.74 - $117.27 $23,426 - $31,311
267 Added 5.4%
5,209 $506,000
Q4 2022

Feb 02, 2023

BUY
$80.93 - $108.63 $566 - $760
7 Added 0.14%
4,942 $511,000
Q2 2022

Aug 08, 2022

SELL
$71.48 - $86.85 $20,657 - $25,099
-289 Reduced 5.53%
4,935 $409,000
Q1 2022

May 05, 2022

SELL
$74.28 - $92.69 $91,512 - $114,194
-1,232 Reduced 19.08%
5,224 $403,000
Q3 2021

Nov 05, 2021

SELL
$74.77 - $85.47 $1,420 - $1,623
-19 Reduced 0.29%
6,456 $498,000
Q2 2021

Aug 09, 2021

BUY
$75.51 - $84.79 $1,434 - $1,611
19 Added 0.29%
6,475 $540,000
Q1 2021

May 10, 2021

BUY
$74.73 - $90.69 $482,456 - $585,494
6,456 New
6,456 $487,000
Q3 2019

Nov 08, 2019

SELL
$67.4 - $85.11 $18,535 - $23,405
-275 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$80.35 - $93.9 $803 - $939
-10 Reduced 3.51%
275 $0
Q1 2019

May 10, 2019

SELL
$84.2 - $98.62 $421 - $493
-5 Reduced 1.72%
285 $0
Q4 2018

Feb 12, 2019

SELL
$80.14 - $106.07 $17,630 - $23,335
-220 Reduced 43.14%
290 $25,000
Q3 2018

Nov 07, 2018

SELL
$93.92 - $105.72 $10,800 - $12,157
-115 Reduced 18.4%
510 $49,000
Q2 2018

Aug 15, 2018

BUY
$76.01 - $99.03 $380 - $495
5 Added 0.81%
625 $59,000
Q4 2017

Jan 31, 2018

SELL
$80.76 - $95.13 $807 - $951
-10 Reduced 1.59%
620 $55,000
Q2 2017

Aug 14, 2017

BUY
N/A
630
630 $57,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.